DK1150996T3 - Nye amidinobenzylaminderivater og deres anvendelse som thrombin-inhibitorer - Google Patents

Nye amidinobenzylaminderivater og deres anvendelse som thrombin-inhibitorer

Info

Publication number
DK1150996T3
DK1150996T3 DK00902233T DK00902233T DK1150996T3 DK 1150996 T3 DK1150996 T3 DK 1150996T3 DK 00902233 T DK00902233 T DK 00902233T DK 00902233 T DK00902233 T DK 00902233T DK 1150996 T3 DK1150996 T3 DK 1150996T3
Authority
DK
Denmark
Prior art keywords
novel
thrombin inhibitors
amidinobenzylamine
derivatives
amidinobenzylamine derivatives
Prior art date
Application number
DK00902233T
Other languages
English (en)
Inventor
Tord Inghardt
Jan-Erik Nystroem
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9900071A external-priority patent/SE9900071D0/xx
Priority claimed from SE9904228A external-priority patent/SE9904228D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK1150996T3 publication Critical patent/DK1150996T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK00902233T 1999-01-13 2000-01-13 Nye amidinobenzylaminderivater og deres anvendelse som thrombin-inhibitorer DK1150996T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9900071A SE9900071D0 (sv) 1999-01-13 1999-01-13 New compounds
SE9904228A SE9904228D0 (sv) 1999-11-22 1999-11-22 New compounds
PCT/SE2000/000052 WO2000042059A1 (en) 1999-01-13 2000-01-13 New amidinobenzylamine derivatives and their use as thrombin inhibitors

Publications (1)

Publication Number Publication Date
DK1150996T3 true DK1150996T3 (da) 2008-02-11

Family

ID=26663479

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00902233T DK1150996T3 (da) 1999-01-13 2000-01-13 Nye amidinobenzylaminderivater og deres anvendelse som thrombin-inhibitorer

Country Status (22)

Country Link
US (1) US6599894B1 (da)
EP (1) EP1150996B1 (da)
JP (1) JP2002535250A (da)
KR (1) KR100639274B1 (da)
CN (1) CN1170842C (da)
AU (1) AU764121B2 (da)
BR (1) BR0007453A (da)
CA (1) CA2355792A1 (da)
CY (1) CY1107149T1 (da)
CZ (1) CZ20012529A3 (da)
DE (1) DE60037183T2 (da)
DK (1) DK1150996T3 (da)
EE (1) EE200100371A (da)
ES (1) ES2295004T3 (da)
IL (1) IL143987A (da)
IS (1) IS5990A (da)
NO (1) NO20013319L (da)
NZ (1) NZ512714A (da)
PL (1) PL349769A1 (da)
PT (1) PT1150996E (da)
TR (1) TR200102037T2 (da)
WO (1) WO2000042059A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0001803D0 (sv) * 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
US6433186B1 (en) 2000-08-16 2002-08-13 Astrazeneca Ab Amidino derivatives and their use as thormbin inhibitors
JP2004506039A (ja) * 2000-08-16 2004-02-26 アストラゼネカ　アクチボラグ 新規なアミジノ誘導体と、トロンビン阻害剤としてのそれらの使用
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
SE0102921D0 (sv) * 2001-08-30 2001-08-30 Astrazeneca Ab Pharmaceutically useful compounds
US7129233B2 (en) 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
UA78195C2 (uk) * 2001-08-30 2007-03-15 Astrazeneca Ab Похідні мигдалевої кислоти та їх застосування як інгібіторів тромбіну, фармацевтична композиція на їх основі
EP1432687A2 (en) * 2001-10-03 2004-06-30 Pharmacia Corporation Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
SE0201661D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201658D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Immediate release pharmaceutical formulation
SE0201659D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
US7524354B2 (en) * 2005-07-07 2009-04-28 Research Foundation Of State University Of New York Controlled synthesis of highly monodispersed gold nanoparticles
TW200827336A (en) * 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178398B (en) 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
HU192646B (en) 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
ZA86746B (en) 1985-02-04 1986-09-24 Merrell Dow Pharma Novel peptidase inhibitors
US5187157A (en) 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
EP0362002B1 (en) 1988-09-01 1995-07-26 Merrell Dow Pharmaceuticals Inc. HIV protease inhibitors
ZA897514B (en) 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
TW201303B (da) 1990-07-05 1993-03-01 Hoffmann La Roche
CA2075154A1 (en) 1991-08-06 1993-02-07 Neelakantan Balasubramanian Peptide aldehydes as antithrombotic agents
SE9102462D0 (sv) 1991-08-28 1991-08-28 Astra Ab New isosteric peptides
CZ333492A3 (en) 1991-11-12 1993-09-15 Lilly Co Eli Dipeptide of l-azetidine-2-carboxylic acids and l-argininaldehyde, process of its preparation and pharmaceutical preparation in which said dipeptide is comprised
SE9103612D0 (sv) 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
US5760235A (en) 1992-03-04 1998-06-02 Gyogyszerkutato Intezet Kft. Anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for preparation thereof
TW223629B (da) 1992-03-06 1994-05-11 Hoffmann La Roche
SE9301916D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
EP0648780A1 (en) 1993-08-26 1995-04-19 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
TW394760B (en) 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
CA2140598C (en) 1994-01-27 2010-03-09 Masahiro Ohshima Prolineamide derivatives
ZA951617B (en) 1994-03-04 1997-02-27 Lilly Co Eli Antithrombotic agents.
US5705487A (en) 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5707966A (en) 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
DE4421052A1 (de) 1994-06-17 1995-12-21 Basf Ag Neue Thrombininhibitoren, ihre Herstellung und Verwendung
US5510369A (en) 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
MX9706069A (es) 1995-02-17 1997-10-31 Basf Ag Nuevos inhibidores de la trombina.
US5710130A (en) 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
AU698911B2 (en) 1995-04-04 1998-11-12 Merck & Co., Inc. Thrombin inhibitors
US5629324A (en) 1995-04-10 1997-05-13 Merck & Co., Inc. Thrombin inhibitors
SA96170106A (ar) * 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
AR005245A1 (es) 1995-12-21 1999-04-28 Astrazeneca Ab Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion
AU1990197A (en) 1996-03-12 1997-10-01 Bristol-Myers Squibb Company Carbamyl guanidine and amidine prodrugs
SE9602263D0 (sv) 1996-06-07 1996-06-07 Astra Ab New amino acid derivatives
WO1997049404A1 (en) 1996-06-25 1997-12-31 Eli Lilly And Company Anticoagulant agents
DE19632772A1 (de) 1996-08-14 1998-02-19 Basf Ag Neue Benzamidine
AR013084A1 (es) 1997-06-19 2000-12-13 Astrazeneca Ab Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados

Also Published As

Publication number Publication date
AU764121B2 (en) 2003-08-07
ES2295004T3 (es) 2008-04-16
BR0007453A (pt) 2001-10-30
NZ512714A (en) 2003-10-31
DE60037183T2 (de) 2008-10-09
KR100639274B1 (ko) 2006-10-27
CA2355792A1 (en) 2000-07-20
PL349769A1 (en) 2002-09-09
JP2002535250A (ja) 2002-10-22
DE60037183D1 (de) 2008-01-03
KR20010101493A (ko) 2001-11-14
IL143987A (en) 2005-12-18
CN1343217A (zh) 2002-04-03
CN1170842C (zh) 2004-10-13
NO20013319D0 (no) 2001-07-04
CZ20012529A3 (cs) 2001-11-14
IL143987A0 (en) 2002-04-21
US6599894B1 (en) 2003-07-29
WO2000042059A1 (en) 2000-07-20
TR200102037T2 (tr) 2001-10-22
EP1150996A1 (en) 2001-11-07
EP1150996B1 (en) 2007-11-21
CY1107149T1 (el) 2012-10-24
AU2336200A (en) 2000-08-01
EE200100371A (et) 2002-02-15
NO20013319L (no) 2001-09-12
IS5990A (is) 2001-07-05
PT1150996E (pt) 2008-01-15

Similar Documents

Publication Publication Date Title
DK1347955T3 (da) Nye mandelsyrederivater og deres anvendelse som throbin-hæmmere
NO20026010D0 (no) Substituerte quinazolinderivater og deres anvendelse som inhibitorer
NO996313L (no) Nye amidinoderivater og deres anvendelse som trombininhibitorer
NO20034187L (no) Nye spirotricykliske derivater og anvendelse derav som fosfodiesterase-7 inhibitorer
NO986180D0 (no) Nye amidinoderivater og deres anvendelse som trombininhibitorer
NO20030298D0 (no) Nye heteroarylderivater og deres anvendelse som farmasöytiske midler
DK1133477T3 (da) Substituerede benzimidazoler og deres anvendelse som parpinhibitorer
NO20030302D0 (no) Nye heteroarylderivater og deres anvendelse som medikamenter
DK1527050T3 (da) Quinolin-derivater og deres anvendelse som mycobakterielle inhibitorer
NO20032830D0 (no) Tetrahydropyridinderivater, fremstilling derav og anvendelse som celle-proliferasjonsinhibitorer
NO20014135D0 (no) Nye sulfonamidforbindelser og deres anvendelse
NO20013452D0 (no) Benzoheterocykler og deres anvendelse som MEK-inhibitorer
DK0910573T3 (da) Nye aminosyrederivater og deres anvendelse som thrombininhibitorer
NO20034324L (no) Bipiperidinylderivater og deres anvendelse som kjemokin reseptorinhibitor
NO20042719L (no) Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer
DK1150996T3 (da) Nye amidinobenzylaminderivater og deres anvendelse som thrombin-inhibitorer
NO20030382D0 (no) Nye indolderivater og deres anvendelse som medikamenter
NO20035328D0 (no) Nye forbindelser og preparater som katepsinhibitorer
NO20025504D0 (no) Nye tiokromanderivater og anvendelse derav som trombininhibitorer
DK1214302T3 (da) Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere
NO20023951D0 (no) Arylpiperaziner og arylpiperidiner og deres anvendelse som metalloproteinaseinhiberende midler
NO20030813D0 (no) Bifenylderivater og deres anvendelse som integrininhibitorer
NO20025884L (no) 2-aminotiazolinderivater og deres anvendelse som NO- syntaseinhibitorer
DK1200409T3 (da) Substituerede isoquinolinderivater og deres anvendelse som krampestillende midler
NO20014149D0 (no) Nye dipeptidforbindelser og deres anvendelse som medisiner